Research Advisory Council (RAC) Members of our Low-Grade Glioma Registry OPTIMUM project gather as part of the Quality of Life Roundtable Meeting in Washington, DC with the National Brain Tumor Society - May 2023.

Research Advisory Council (RAC) Members of our Low-Grade Glioma Registry OPTIMUM project gather as part of the Quality of Life Roundtable Meeting in Washington, DC with the National Brain Tumor Society - May 2023.

LGG Registry and OPTIMUM research associate, Annie Heffernan, MPH, was presented with a Junior Investigator Award, sponsored by the American Brain Tumor Association (2023 Brain Tumor Epidemiology Consortium Annual Meeting). You may read more of her w

LGG Registry and OPTIMUM research associate, Annie Heffernan, MPH, was presented with a Junior Investigator Award, sponsored by the American Brain Tumor Association (2023 Brain Tumor Epidemiology Consortium Annual Meeting). You may read more of her work at: https://pe-cgs.org/resources/

The Genomic Characterization Unit (GCU) at OPTIMUM is led by co-Principal Investigator Roel Verhaak, PhD. The GCU is responsible for studying genetic changes among recurrent glioma tumors.

The Genomic Characterization Unit (GCU) at OPTIMUM is led by co-Principal Investigator Roel Verhaak, PhD. The GCU is responsible for studying genetic changes among recurrent glioma tumors.

Annie Heffernan (right), LGG Registry/OPTIMUM research associate, represents the Brigham and Women's Department of Neurosurgery at the 2023 NBTS New England Brain Tumor Walk.

Annie Heffernan (right), LGG Registry/OPTIMUM research associate, represents the Brigham and Women's Department of Neurosurgery at the 2023 NBTS New England Brain Tumor Walk.

Annie Heffernan (Research Associate, right), Elizabeth Claus (LGG Registry founder, center), and Mathew Krick (Research Associate, left) representing OPTIMUM's Participant Engagement Unit (PEU) at the Participant Engagement in Cancer Genomic Sequenci

Annie Heffernan (Research Associate, right), Elizabeth Claus (LGG Registry founder, center), and Mathew Krick (Research Associate, left) representing OPTIMUM's Participant Engagement Unit (PEU) at the Participant Engagement in Cancer Genomic Sequencing annual meeting in Albuquerque, New Mexico.

OPTIMUM team members gather at the 2023 Participant Engagement and Cancer Genomic Sequencing (PE-CGS) Annual Meeting in Albuquerque, New Mexico. PE-CGS is a broader network for which OPTIMUM is a part of.

OPTIMUM team members gather at the 2023 Participant Engagement and Cancer Genomic Sequencing (PE-CGS) Annual Meeting in Albuquerque, New Mexico. PE-CGS is a broader network for which OPTIMUM is a part of.